[Federal Register: June 5, 2003 (Volume 68, Number 108)]
[Notices]               
[Page 33720-33723]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr05jn03-85]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

 
Request for Nominations for Voting Members on Public Advisory 
Panels or Committees

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is requesting 
nominations for voting members to serve on certain device panels of the 
Medical Devices Advisory Committee, the National Mammography Quality 
Assurance Advisory Committee, the Device Good Manufacturing Practice 
Advisory Committee, and the Technical Electronic Products Radiation 
Safety Standards Committee in the Center for Devices and Radiological 
Health. Nominations will be accepted for current vacancies and those 
that will or may occur through August 31, 2004.
    FDA has a special interest in ensuring that women, minority groups, 
and individuals with disabilities are adequately represented on 
advisory committees and, therefore, encourages nominations of qualified 
candidates from these groups.

DATES: Because scheduled vacancies occur on various dates throughout 
each year, no cutoff date is established for the receipt of 
nominations. However, when possible, nominations should be received at 
least 6 months before the date of scheduled vacancies for each year, as 
indicated in this notice.

ADDRESSES: Send all nominations and curricula vitae to:
    1. For the device panels: Nancy J. Pluhowski, Center for Devices 
and Radiological Health (HFZ-400), Food and Drug Administration, 9200 
Corporate Blvd., Rockville, MD 20850, 301-594-2022, e-mail: 
NJP@CDRH.FDA.GOV.
[[Page 33721]]

    2. For the National Mammography Quality Assurance Advisory 
Committee, excluding consumer representatives: Charles A. Finder, 
Center for Devices and Radiological Health (HFZ-240), Food and Drug 
Administration, 1350 Piccard Dr., Rockville, MD 20850, e-mail: 
CAF@CDRH.FDA.GOV.    3. For health professional, industry representatives and government 
representatives for the Device Good Manufacturing Practice Advisory 
Committee: Sharon Kalokerinos, Center for Devices and Radiological 
Health (HFZ-300), Food and Drug Administration, 2094 Gaither Rd., 
Rockville, MD 20850, e-mail: SMK@CDRH.FDA.GOV.    4: For government representatives and industry representatives for 
the Technical Electronic Product Radiation Safety Standards Committee: 
Richard V. Kaczmarek, Center for Devices and Radiological Health (HFZ-
240), Food and Drug Administration, 1350 Piccard Dr., Rockville, MD 
20850, RVK@CDRH.FDA.GOV.
FOR FURTHER INFORMATION CONTACT: Kathleen L. Walker, Center for Devices 
and Radiological Health (HFZ-17), Food and Drug Administration, 2098 
Gaither Rd., Rockville, MD 20850, 301-594-1283, ext. 114, e-mail: 
KLW@CDRH.FDA.GOV.
SUPPLEMENTARY INFORMATION:

I. Vacancies

    FDA is requesting nominations of voting members for vacancies 
listed as follows:
    1. Anesthesiology and Respiratory Therapy Devices Panel: Four 
vacancies immediately, one vacancy occurring November 30, 2003; 
anesthesiologists, pulmonary medicine specialists, or other experts who 
have specialized interests in ventilatory support, pharmacology, 
physiology, or the effects and complications of anesthesia.
    2. Circulatory System Devices Panel: Three vacancies occurring June 
30, 2004; interventional cardiologists, electrophysiologists, invasive 
(vascular) radiologists, vascular and cardiothoracic surgeons, and 
cardiologists with special interest in congestive heart failure.
    3. Clinical Chemistry and Clinical Toxicology Devices Panel: Three 
vacancies occurring February 28, 2004; doctors of medicine or 
philosophy with experience in clinical chemistry, clinical toxicology, 
clinical pathology, and/or clinical laboratory medicine.
    4. Dental Products Panel: Two vacancies immediately, three 
vacancies occurring October 31, 2003; dentists, engineers and 
scientists who have expertise in the areas of lasers, temporomandibular 
joint implants and/or endodontics; or experts in tissue engineering 
and/or bone physiology relative to the oral and maxillofacial area.
    5. General and Plastic Surgery Devices Panel: Four vacancies 
immediately, one vacancy occurring August 31, 2003; general surgeons, 
plastic surgeons, thoracic surgeons, abdominal surgeons, pelvic 
surgeons and reconstructive surgeons, biomaterials experts, laser 
experts, wound healing experts, or endoscopic surgery experts.
    6. Hematology and Pathology Devices Panel: Three vacancies 
immediately; hematologists (benign and/or malignant hematology), 
hematopathologists (general and special hematology, coagulation and 
hemostasis, and hematological oncology), gynecologists with special 
interests in gynecological oncology, cytopathologists, and molecular 
biologists with special interests in development of predictive and 
prognostic biomarkers.
    7. Immunology Devices Panel: Three vacancies occurring February 28, 
2004; persons with experience in medical, surgical, or clinical 
oncology, internal medicine, clinical immunology, allergy, molecular 
diagnostics, or clinical laboratory medicine.
    8. Molecular and Clinical Genetics Devices Panel: Four vacancies 
occurring May 31, 2004; experts in human genetics and in the clinical 
management of patients with genetic disorders, e.g., pediatricians, 
obstetricians, neonatologists. The agency is also interested in 
considering candidates with training in inborn errors of metabolism, 
biochemical and/or molecular genetics, population genetics, 
epidemiology and related statistical training. Additionally, 
individuals with experience in genetic counseling, medical ethics as 
well as ancillary fields of study will be considered.
    9. Obstetrics and Gynecology Devices Panel: One vacancy occurring 
January 31, 2004; experts in perinatology, embryology, reproductive 
endocrinology, operative hysteroscopy, pelviscopy, electrosurgery, 
laser surgery, assisted reproductive technologies, contraception, post-
operative adhesions, and cervical cancer and colposcopy; 
biostatisticians and engineers with experience in obstetrics/gynecology 
devices; urogynecologists; experts in breast care; expert in gynecology 
in the older patient; experts in diagnostic (optical) spectroscopy.
    10. Ophthalmic Devices Panel: One vacancy occurring October 31, 
2003; ophthalmologists specializing in cataract and refractive surgery, 
vitreo-retinal surgery, pediatric ophthalmology, and the treatment of 
glaucoma; in addition to vision scientists, electrophysiologists, and 
optometrists.
    11. Orthopaedic and Rehabilitation Devices Panel: Two vacancies 
occurring August 31, 2004; doctors of medicine or philosophy with 
experience in tissue engineering, calcification or biomaterials; 
orthopedic surgeons experienced with prosthetic ligament devices, joint 
implants, or spinal instrumentation; physical therapists experienced in 
spinal cord injuries, neurophysiology, electrotherapy, and joint 
biomechanics; rheumatologists; or biomedical engineers.
    12. Radiological Devices Panel: One vacancy immediately, two 
vacancies occurring January 31, 2004; statistician with biomedical 
expertise including the design of clinical trials, ROC (receiver 
operating characteristic) analysis, diagnostic test evaluation, and 
data testing.
    13. National Mammography Quality Assurance Advisory Committee: 
Three vacancies occurring January 31, 2004; physician, practitioner, or 
other health professional whose clinical practice, research 
specialization, or professional expertise includes a significant focus 
on mammography.
    14. Device Good Manufacturing Practice Advisory Committee: six 
vacancies occurring immediately; three government representatives, two 
industry representatives, and one health professional.
    15. Technical Electronic Product Radiation Safety Standards 
Committee: Four vacancies immediately, one government representative 
and three industry representatives; three vacancies occurring December 
31, 2003, two government representatives and one industry 
representative.

II. Functions

A. Medical Devices Advisory Committee

    The committee reviews and evaluates data on the safety and 
effectiveness of marketed and investigational devices and makes 
recommendations for their regulation. The panels engage in a number of 
activities to fulfill the functions the Federal Food, Drug, and 
Cosmetic Act (the act) envisions for device advisory panels. With the 
exception of the Medical Devices Dispute Resolution Panel, each panel, 
according to its specialty area: (1) Advises the Commissioner of Food 
and Drugs (the Commissioner) regarding recommended classification or 
reclassification of devices into one of three regulatory categories, 
(2) advises on any possible risks to health

[[Page 33722]]

associated with the use of devices, (3) advises on formulation of 
product development protocols, (4) reviews premarket approval 
applications for medical devices, (5) reviews guidelines and guidance 
documents, (6) recommends exemption of certain devices from the 
application of portions of the act, (7) advises on the necessity to ban 
a device, and (8) responds to requests from the agency to review and 
make recommendations on specific issues or problems concerning the 
safety and effectiveness of devices. With the exception of the Medical 
Devices Dispute Resolution Panel, each panel, according to its 
specialty area, may also make appropriate recommendations to the 
Commissioner on issues relating to the design of clinical studies 
regarding the safety and effectiveness of marketed and investigational 
devices.
    The Dental Products Panel also functions at times as a dental drug 
panel. The functions of the dental drug panel are to evaluate and 
recommend whether various prescription drug products should be changed 
to over-the-counter status and to evaluate data and make 
recommendations concerning the approval of new dental drug products for 
human use.
    The Medical Devices Dispute Resolution Panel provides advice to the 
Commissioner on complex or contested scientific issues between FDA and 
medical device sponsors, applicants, or manufacturers relating to 
specific products, marketing applications, regulatory decisions and 
actions by FDA, and agency guidance and policies. The panel makes 
recommendations on issues that are lacking resolution, are highly 
complex in nature, or result from challenges to regular advisory panel 
proceedings or agency decisions or actions.

B. National Mammography Quality Assurance Advisory Committee

    The functions of the committee are to advise FDA on: (1) Developing 
appropriate quality standards and regulations for mammography 
facilities, (2) developing appropriate standards and regulations for 
bodies accrediting mammography facilities under this program, (3) 
developing regulations with respect to sanctions, (4) developing 
procedures for monitoring compliance with standards, (5) establishing a 
mechanism to investigate consumer complaints, (6) reporting new 
developments concerning breast imaging which should be considered in 
the oversight of mammography facilities, (7) determining whether there 
exists a shortage of mammography facilities in rural and health 
professional shortage areas and determining the effects of personnel on 
access to the services of such facilities in such areas, (8) 
determining whether there will exist a sufficient number of medical 
physicists after October 1, 1999, and (9) determining the costs and 
benefits of compliance with these requirements.

C. Device Good Manufacturing Practice Advisory Committee

    The functions of the committee are to review proposed regulations 
for promulgation regarding good manufacturing practices governing the 
methods used in, and the facilities and controls used for manufacture, 
packaging, storage, installation, and servicing of devices, and make 
recommendations regarding the feasibility and reasonableness of those 
proposed regulations. The committee also reviews and makes 
recommendations on proposed guidelines developed to assist the medical 
device industry in meeting the good manufacturing practice 
requirements, and provides advice with regard to any petition submitted 
by a manufacturer for an exemption or variance from good manufacturing 
practice regulations.
    Section 520 of the act (21 U.S.C. 360j), as amended, provides that 
the Device Good Manufacturing Practice Advisory Committee shall be 
composed of nine members as follows: (1) Three of the members shall be 
appointed from persons who are officers or employees of any Federal, 
State, or local government; (2) two shall be representatives of 
interests of the device manufacturing industry; (3) two shall be 
representatives of the interests of physicians and other health 
professionals; and (4) two shall be representatives of the interests of 
the general public.

D. Technical Electronic Product Radiation Safety Standards Committee

    The function of the committee is to provide advice and consultation 
on the technical feasibility, reasonableness, and practicability of 
performance standards for electronic products to control the emission 
of radiation from such products. The committee may recommend electronic 
product radiation safety standards for consideration.
    Section 534(f) of the act, as amended by the Safe Medical Devices 
Act of 1990 (21 U.S.C. 360kk(f)), provides that the Technical 
Electronic Product Radiation Safety Standards Committee include five 
members from governmental agencies, including State or Federal 
Governments, five members from the affected industries, and five 
members from the general public, of which at least one shall be a 
representative of organized labor.

III. Qualifications

A. Panels of the Medical Devices Advisory Committee

    Persons nominated for membership on the panels shall have 
adequately diversified experience appropriate to the work of the panel 
in such fields as clinical and administrative medicine, engineering, 
biological and physical sciences, statistics, and other related 
professions. The nature of specialized training and experience 
necessary to qualify the nominee as an expert suitable for appointment 
may include experience in medical practice, teaching, and/or research 
relevant to the field of activity of the panel. The particular needs at 
this time for each panel are listed in section I of this document. The 
term of office is up to 4 years, depending on the appointment date.

B. National Mammography Quality Assurance Advisory Committee

    Persons nominated for membership should be physicians, 
practitioners, and other health professionals, whose clinical practice, 
research specialization, or professional expertise include a 
significant focus on mammography and individuals identified with 
consumer interests. Prior experience on Federal public advisory 
committees in the same or similar subject areas will also be considered 
relevant professional expertise. The particular needs at this time for 
each panel are listed in section I of this document. The term of office 
is up to 4 years, depending on the appointment date.

C. Device Good Manufacturing Practice Advisory Committee

    Persons nominated for membership as a government representative or 
health professional should have knowledge of or expertise in any one or 
more of the following areas: quality assurance concerning the design, 
manufacture, and use of medical devices. To be eligible for selection 
as a representative of the general public or industry, nominees should 
possess appropriate qualifications to understand and contribute to the 
committee's work. The particular needs at this time for each panel are 
listed in section I of this document. The term of office is up to 4 
years, depending on the appointment date.

[[Page 33723]]

D. Technical Electronic Product Radiation Safety Standards Committee

    Persons nominated must be technically qualified by training and 
experience in one or more fields of science or engineering applicable 
to electronic product radiation safety. The particular needs at this 
time for each panel are listed in section I of this document. The term 
of office is up to 4 years, depending on the appointment date.

IV. Nomination Procedures

    Any interested person may nominate one or more qualified persons 
for membership on one or more of the advisory panels or advisory 
committees. Self-nominations are also accepted. Nominations shall 
include complete curriculum vitae of each nominee, current business 
address and telephone number, and shall state that the nominee is aware 
of the nomination, is willing to serve as a member, and appears to have 
no conflict of interest that would preclude membership. FDA will ask 
the potential candidates to provide detailed information concerning 
such matters as financial holdings, employment, and research grants 
and/or contracts to permit evaluation of possible sources of conflict 
of interest.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14 relating to advisory committees.

    Dated: May 29, 2003.
Peter J. Pitts,
Associate Commissioner for External Relations.
[FR Doc. 03-14210 Filed 6-4-03; 8:45 am]

BILLING CODE 4160-01-S